Indications/Uses
Listed in Dosage.
|
Dosage/Direction for Use
Adult: PO Painful and inflammatory conditions of oropharynx As loz: Dissolve 1 loz slowly in the mouth tid. Alternatively, suck 1 loz 1-2 hourly or as needed (Max: 12 loz/day). Dosing may vary between countries, refer to detailed product guideline for specific dosing information. Max treatment duration: 7 days. Mouth/Throat Painful and inflammatory conditions of oropharynx As 0.15% w/v spray: 4-8 sprays 1.5-3 hourly. As 0.30% w/v spray: 2-4 sprays 1.5-3 hourly. As 0.15% w/v mouthwash or gargle: Rinse or gargle 15 mL 1.5-3 hourly as required. May dilute solution with equal volume of water if stinging occurs. Max treatment duration for all dosage forms: 7 days. Topical Pain and inflammation associated with musculoskeletal and joint disorders As 3% cream: Apply 35-85 mm (1-2 g) onto the affected area tid, or for up to 6 times/day at the prescriber's discretion in severe conditions. Max treatment duration: 10 days.
|
Contraindications
Hypersensitivity to benzydamine, aspirin, or other NSAIDs.
|
Special Precautions
Patient with existing or history of bronchial asthma, untreated bacterial throat infection. Renal and severe hepatic impairment. Children. Patient Counselling Cream: Avoid smoking or going near naked flames due to risk of burns.
|
Adverse Reactions
Significant: Local irritation and burning sensation. Rarely, bronchospasm.
Gastrointestinal disorders: Oral hypoaesthesia, dry mouth; nausea, vomiting.
Immune system disorders: Hypersensitivity reactions. Rarely, angioedema.
Metabolism and nutrition disorders: Thirst.
Nervous system disorders: Headache, drowsiness.
Respiratory, thoracic and mediastinal disorders: Rarely, laryngospasm.
Skin and subcutaneous tissue disorders: Photosensitivity reaction, rash, pruritus, erythema, papular eruption.
Potentially Fatal: Anaphylactic reaction. |
ATC Classification
R02AX03 - benzydamine ; Belongs to the class of other throat preparations.
M01AX07 - benzydamine ; Belongs to the class of other non-steroidal antiinflammatory and antirheumatic products. A01AD02 - benzydamine ; Belongs to the class of other agents for local oral treatment. G02CC03 - benzydamine ; Belongs to the class of antiinflammatory products for vaginal administration used in the treatment and prevention of inflammation. M02AA05 - benzydamine ; Belongs to the class of non-steroidal antiinflammatory preparations for topical use. Used in the treatment of joint and muscular pains. |